Literature DB >> 25366546

The influence of polysorbate 80 on the radiochemical synthesis of a PET tracer in the FASTlab.

Wai Lam Yip1, Sverre Arne Sande, David Grace, Dirk Jan in't Veld, Per Christian Sontum, Tina Solvang, Knut Dyrstad.   

Abstract

PURPOSE: The aim of current study was to investigate the influence of a common non-ionic surfactant, polysorbate 80 (PS80), on radioactive labelling process of a novel PET tracer, [(18)F]Flutemetamol.
METHODS: Ferrous oxidation-xylenol orange (FOX) assay, in addition to UV/VIS and (1)H NMR spectroscopies were applied to characterise the composition of the PS80 solution after storage. Multivariate Curve Resolution (MCR) and PLS analysis was used to establish correlation between quality of the PS80 solution and the RCP obtained after labelling.
RESULTS: The levels of unsaturated fatty acid moieties of PS80 were negatively correlated to RCP of [(18)F]Flutemetamol after synthesis. This explains the slight increase in RCP when stored PS80 solutions were applied in the synthesis. The mechanism behind this observation is suggested to be related to radiation induced radical formation in the unsaturated fatty acids, which subsequently causes instability of the PET tracer. UV/VIS spectroscopy was demonstrated to have the ability as a possible control tool for quality assurance of the studied radioactive labelling process.
CONCLUSIONS: The presence of unsaturated fatty acid moieties in PS80 was found to be one of the most important factors responsible for the reduction in RCP of [(18)F]Flutemetamol after synthesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25366546     DOI: 10.1007/s11095-014-1547-4

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  24 in total

Review 1.  Characterization, formulation, and stability of Neupogen (Filgrastim), a recombinant human granulocyte-colony stimulating factor.

Authors:  A C Herman; T C Boone; H S Lu
Journal:  Pharm Biotechnol       Date:  1996

2.  Positron emission tomography with [18F]flutemetamol and [11C]PiB for in vivo detection of cerebral cortical amyloid in normal pressure hydrocephalus patients.

Authors:  V Leinonen; J O Rinne; K A Virtanen; O Eskola; J Rummukainen; J Huttunen; M von Und Zu Fraunberg; O Nerg; A M Koivisto; J Rinne; J E Jääskeläinen; C Buckley; A Smith; P A Jones; P Sherwin; G Farrar; R McLain; M Kailajärvi; K Heurling; I D Grachev
Journal:  Eur J Neurol       Date:  2013-02-11       Impact factor: 6.089

3.  Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study.

Authors:  Henryk Barthel; Hermann-Josef Gertz; Stefan Dresel; Oliver Peters; Peter Bartenstein; Katharina Buerger; Florian Hiemeyer; Sabine M Wittemer-Rump; John Seibyl; Cornelia Reininger; Osama Sabri
Journal:  Lancet Neurol       Date:  2011-04-08       Impact factor: 44.182

4.  18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.

Authors:  Rik Vandenberghe; Koen Van Laere; Adrian Ivanoiu; Eric Salmon; Christine Bastin; Eric Triau; Steen Hasselbalch; Ian Law; Allan Andersen; Alex Korner; Lennart Minthon; Gaëtan Garraux; Natalie Nelissen; Guy Bormans; Chris Buckley; Rikard Owenius; Lennart Thurfjell; Gill Farrar; David J Brooks
Journal:  Ann Neurol       Date:  2010-09       Impact factor: 10.422

5.  The degradation of polysorbates 20 and 80 and its potential impact on the stability of biotherapeutics.

Authors:  Ravuri S K Kishore; Sylvia Kiese; Stefan Fischer; Astrid Pappenberger; Ulla Grauschopf; Hanns-Christian Mahler
Journal:  Pharm Res       Date:  2011-03-03       Impact factor: 4.200

6.  Silver-ion high-performance liquid chromatographic separation and identification of conjugated linoleic acid isomers.

Authors:  N Sehat; M P Yurawecz; J A Roach; M M Mossoba; J K Kramer; Y Ku
Journal:  Lipids       Date:  1998-02       Impact factor: 1.880

7.  Degradation of polysorbates 20 and 80: studies on thermal autoxidation and hydrolysis.

Authors:  Ravuri S K Kishore; Astrid Pappenberger; Isabelle Bauer Dauphin; Alfred Ross; Beatrice Buergi; Andreas Staempfli; Hanns-Christian Mahler
Journal:  J Pharm Sci       Date:  2010-08-27       Impact factor: 3.534

8.  Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease.

Authors:  Natalie Nelissen; Koen Van Laere; Lennart Thurfjell; Rikard Owenius; Mathieu Vandenbulcke; Michel Koole; Guy Bormans; David J Brooks; Rik Vandenberghe
Journal:  J Nucl Med       Date:  2009-07-17       Impact factor: 10.057

9.  Polysorbate 80 UV/vis spectral and chromatographic characteristics--defining boundary conditions for use of the surfactant in dissolution analysis.

Authors:  W Peter Wuelfing; Kathryn Kosuda; Allen C Templeton; Amy Harman; Mark D Mowery; Robert A Reed
Journal:  J Pharm Biomed Anal       Date:  2006-03-06       Impact factor: 3.935

10.  Combination of biomarkers: PET [18F]flutemetamol imaging and structural MRI in dementia and mild cognitive impairment.

Authors:  Lennart Thurfjell; Jyrki Lötjönen; Roger Lundqvist; Juha Koikkalainen; Hilkka Soininen; Gunhild Waldemar; David J Brooks; Rik Vandenberghe
Journal:  Neurodegener Dis       Date:  2012-02-01       Impact factor: 2.977

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.